Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
Close
Search
Search
Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
Genta Genasense Fails To Demonstrate “Any Clinical Benefit” Improvements, FDA Tells Cmte.
Sep 05 2006
•
By
Brian Marson
More from Archive
More from Pink Sheet